Floatz logo

Monomethyl Fumarate

Relapsed T-Cell Lymphoma

Masonic Cancer Center, University of MinnesotaSmall moleculePhase 2Active
BB
71/ 100
Provisional rating · Methodology v0.2

Rating breakdown

Clinical Evidence
56/ 100
Competitive Position
95/ 100

Competitive context

5 Active assets in the Relapsed T-Cell Lymphoma cohort.

Asset / SponsorPhaseRating
Fludarabine
GC Cell Corporation
Phase 2BBB
FILGRASTIM
Sichuan University
Phase 3BB
Rapamycin
Masonic Cancer Center, University of Minnesota
Phase 2B
ALLOGENEIC HUMAN UMBILICAL CORD BLOOD
Masonic Cancer Center, University of Minnesota
Phase 2B
Umbilical Cord Blood Mononuclear Cells
Masonic Cancer Center, University of Minnesota
Phase 2B

View all 9 →

Same molecule, other indications

Monomethyl Fumarate is also rated in:

Blood Stem Cell Transplant FailureDormant
BBB
Indicative ·
76 / 100
View asset →
Fanconi AnemiaDormant
BBB
Indicative ·
74 / 100
View asset →
Refractory Anemia With Excess BlastsDormant
BBB
Indicative ·
73 / 100
View asset →

Need depth?

Order a full diligence report on this asset.

Order report →

Are you the sponsor?

Submit your data room for a Verified Rating. The public-data rating remains visible alongside.

Contact →